Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment
Journal of Infection and Public Health · 2024
DOI: 10.1016/j.jiph.2024.05.048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Infection and Public Health, 2024. Verfasst von Min-Chi Chang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Adenosine Monophosphate, Alanine, COVID-19 Drug Treatment, Antiviral Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Taipei Veterans General Hospital, National Science and Technology Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
- Division of Transfusion Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. El…
- Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. Ele…
Förderung
- Taipei Veterans General Hospital
- National Science and Technology Council
Zitieren
APA
Chang, M. C., Wu, P. F., Ho, Y. C., Lin, W. Y., Wu, C. Y., Liu, S. Y., Liu, C. J., & Lin, Y. T. (2024). Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2024.05.048
Vancouver
Chang MC, Wu PF, Ho YC, Lin WY, Wu CY, Liu SY, et al. Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment. Journal of Infection and Public Health. 2024. doi:10.1016/j.jiph.2024.05.048
BibTeX
@article{Chang2024,
author = {Chang, Min-Chi and Wu, Ping-Feng and Ho, Yu-Chien and Lin, Wen-Ying and Wu, Chia-Ying and Liu, Szu-Yu and Liu, Chia-Jen and Lin, Yi-Tsung},
title = {Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment},
journal = {Journal of Infection and Public Health},
year = {2024},
doi = {10.1016/j.jiph.2024.05.048}
}
EUVIMED